Back to top
more

CSL Limited (CSLLY)

(Delayed Data from OTC)

$99.58 USD

99.58
10,687

-1.18 (-1.17%)

Updated Sep 20, 2024 03:59 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value B Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 31% (79 out of 251)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for CSLLY

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for CSL Limited Sponsored ADR falls in the month of June.

All items in Millions except Per Share data.

6/30/2024 6/30/2023 6/30/2022 6/30/2021 6/30/2020
Assets          
Cash & Equivalents 1,657 1,557 10,441 1,814 1,198
Receivables 3,021 2,236 1,687 1,796 1,739
Notes Receivable 0 0 0 0 0
Inventories 5,964 5,466 4,333 3,781 3,510
Other Current Assets 126 0 0 0 0
Total Current Assets 10,768 9,259 16,461 7,390 6,446
Net Property & Equipment 8,148 7,797 7,017 6,434 5,366
Investments & Advances 163 173 403 22 14
Other Non-Current Assets 0 96 13 7 14
Deferred Charges 911 902 518 530 543
Intangibles 16,346 16,446 2,638 2,670 2,140
Deposits & Other Assets 176 6 5 4 1
Total Assets 38,022 36,234 28,346 18,157 15,465
Liabilities & Shareholders Equity 6/30/2024 6/30/2023 6/30/2022 6/30/2021 6/30/2020
Notes Payable 0 0 0 0 0
Accounts Payable 3,345 2,947 2,301 2,040 1,525
Current Portion Long-Term Debt 944 1,055 4,494 474 202
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 0 0 0 0 0
Income Taxes Payable 176 296 132 313 254
Other Current Liabilities 485 310 182 277 160
Total Current Liabilities 4,950 4,608 7,108 3,104 2,142
Mortgages 0 0 0 0 0
Deferred Taxes/Income 1,514 1,464 670 497 392
Convertible Debt 0 0 0 0 0
Long-Term Debt 11,239 11,172 5,164 5,333 5,791
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 918 1,164 826 842 613
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 18,621 18,408 13,769 9,776 8,937
Shareholders Equity 6/30/2024 6/30/2023 6/30/2022 6/30/2021 6/30/2020
Preferred Stock 0 0 0 0 0
Common Stock (Par) 557 517 484 -4,505 -4,561
Capital Surplus 0 0 0 0 0
Retained Earnings 16,012 14,621 13,503 12,253 10,752
Other Equity 2,832 2,688 590 633 336
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 19,401 17,826 14,578 8,381 6,528
Total Liabilities & Shareholder's Equity 38,022 36,234 28,346 18,157 15,465
Total Common Equity 19,401 17,826 14,578 8,381 6,528
Shares Outstanding 966.50 964.70 963.40 910.20 908.10
Book Value Per Share 20.07 18.48 15.13 9.21 7.19

Fiscal Year End for CSL Limited Sponsored ADR falls in the month of June.

All items in Millions except Per Share data.

6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Assets          
Cash & Equivalents 1,657 -99,999 -98,982 -99,999 1,557
Receivables 3,021 NA 3,563 NA 2,236
Notes Receivable 0 NA NA NA 0
Inventories 5,964 NA 5,566 NA 5,466
Other Current Assets 126 NA NA NA 0
Total Current Assets 10,768 NA 10,146 NA 9,259
Net Property & Equipment 8,148 NA 8,036 NA 7,797
Investments & Advances 163 NA 161 NA 173
Other Non-Current Assets 0 NA NA NA 96
Deferred Charges 911 NA 839 NA 902
Intangibles 16,346 NA 16,467 NA 16,446
Deposits & Other Assets 176 NA 129 NA 6
Total Assets 38,022 NA 37,304 NA 36,234
Liabilities & Shareholders Equity 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Notes Payable 0 NA NA NA 0
Accounts Payable 3,345 NA 2,897 NA 2,947
Current Portion Long-Term Debt 944 NA 1,420 NA 1,055
Current Portion Capital Leases 0 NA NA NA 0
Accrued Expenses 0 NA NA NA 0
Income Taxes Payable 176 NA 132 NA 296
Other Current Liabilities 485 NA 269 NA 310
Total Current Liabilities 4,950 NA 4,718 NA 4,608
Mortgages 0 NA NA NA 0
Deferred Taxes/Income 1,514 NA 1,547 NA 1,464
Convertible Debt 0 NA NA NA 0
Long-Term Debt 11,239 NA 10,687 NA 11,172
Non-Current Capital Leases 0 NA NA NA 0
Other Non-Current Liabilities 918 1,190 NA 1,164
Minority Interest (Liabilities) 0 NA NA NA 0
Total Liabilities 18,621 NA 18,142 NA 18,408
Shareholders Equity 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Preferred Stock 0 NA NA NA 0
Common Stock (Par) 557 NA 537 NA 517
Capital Surplus 0 NA NA NA 0
Retained Earnings 16,012 NA 15,902 NA 14,621
Other Equity 2,832 NA 2,723 NA 2,688
Treasury Stock 0 NA NA NA 0
Total Shareholder's Equity 19,401 NA 19,162 NA 17,826
Total Liabilities & Shareholder's Equity 38,022 NA 37,304 NA 36,234
Total Common Equity 19,401 0 119,161 0 17,826
Shares Outstanding 966.50 966.50 966.10 966.10 964.70
Book Value Per Share 20.07 0.00 123.34 0.00 18.48